X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-positive-top-line-results-of-phase-4-impact-study-of-auryxia-ferric-citrate-for-in-center-and-home-dialysis-patients-301866373.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-24-2021-1614247020.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-22-2020-1595395565.pdf
https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-data-on-different-dosing-regimens-of-ferric-citrate-for-iron-deficiency-anemia-presented-at-57th-era-edta-virtual-congress-301073213.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-collaboration-partners-submission-of-supplemental-new-drug-application-for-use-of-riona-ferric-citrate-hydrate-to-treat-adult-patients-with-iron-deficiency-anemia-in-japan-301060346.html
https://www.businesswire.com/news/home/20191015006126/en/Akebia-Files-Lawsuit-CMS-2018-Action-Rescinding/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J
https://www.businesswire.com/news/home/20181115006066/en/Akebia-Therapeutics-Keryx-Biopharmaceuticals-Announce-Chairperson-Combined
https://www.healthcareglobal.com/public-health/akebia-therapeutics-and-keryx-biopharmaceuticals-merge-creating-1bn-company
https://www.fiercebiotech.com/akebia-keryx-to-merge-creating-kidney-disease-specialist-ahead-showdown-fibrogen-glaxosmithkline
https://www.prnewswire.com/news-releases/weisslaw-llp-investigates-keryx-biopharmaceuticals-inc-300674963.html
https://keryx.gcs-web.com/news-releases/news-release-details/keryx-biopharmaceuticals-announces-data-investigator-sponsored
https://keryx.gcs-web.com/news-releases/news-release-details/keryx-announces-auryxiar-ferric-citrate-now-formulary-all-major
https://keryx.gcs-web.com/news-releases/news-release-details/keryx-biopharmaceuticals-announces-publication-data-phase-3
https://www.in-pharmatechnologist.com/Article/2018/01/04/Keryx-hires-Siegfried-to-make-Auryxia-API
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-3-2018-1514955629.pdf
http://www.fiercepharma.com/marketing/keryx-looks-to-boost-disappointing-auryxia-iron-deficiency-launch
https://keryx.gcs-web.com/news-releases/news-release-details/us-fda-approves-auryxiar-ferric-citrate-tablets-treatment-people
http://www.in-pharmatechnologist.com/Processing/Keryx-Patheon-and-Norwich-sites-will-ensure-supply-of-kidney-drug
http://www.biospace.com/News/keryx-shares-fall-after-manufacturing-of-drug-is/428129/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.fiercepharmamarketing.com/story/keryx-anemia-med-auryxia-trounces-placebo-study-aimed-big-new-use/2016-03-30
https://www.pharmacompass.com/pdf/news/keryxs-fexeric-approved-in-eu-for-hyperphosphatemia-1443869164.pdf
http://www.pharmatimes.com/Article/15-09-24/EU_clears_Keryx_hyperphosphataemia_drug.aspx
http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-newsArticle&id=2001470
Market Place
Share 
